Sentence examples for expanding information on from inspiring English sources

The rapidly expanding information on the structural and functional characteristics of the human genome allows the development of genome-wide approaches to investigate the molecular circuitry wiring the genetic and epigenetic programs of somatic stem cells.

And the tail end of the CD boom is reflected in expanded information on recordings.

But it also includes updated rules, expanded information on policy enforcement to help resolve violations, as well as visual examples and detailed guidelines for the most common violations.

Go online for expanded information on the best places in the U.S. to do business, including rankings of 200 big cities and metro areas and separate rankings of 179 smaller locales.

Subsequent studies, reviewed by Lutsenko et al. [ 42] and Veldhuis et al. [ 43], expanded information on the structural organization and functional properties of the ATP7A and ATP7B isoforms.

These results expand information on the use of combination methotrexate plus TNF inhibitors as a treatment option with substantial therapeutic benefits in patients with early, active RA.

The most recent report for the period 2009 2010 contains expanded information on performance indicators and also includes overall numbers of cytology and histology tests [ 5].

Recent phase III studies have also expanded information on the efficacy of rituximab in methotrexate inadequate responders ('MIRROR' and 'SERENE' studies) 23 24 and addressed methotrexate-naive patients ('IMAGE' study).

We had an active discussion about the value of asking you to include expanded information on the patient and particularly about familial history of the disease in order to link the mutation to the respiratory phenotype.

Maybe, but Microsoft, which could afford to buy all the newspapers in the country, is instead flanking them with its expanding information services on the Internet and on cable.

Under this policy, treatment outside research is allowed only once Phase II has been approved, and then only if Phase I provides expanded information (e.g., on different doses) and if patients can still be monitored for adverse effects.